Skip to main content

Starling Oncology, Inc 10-Q for FY2022 Q3

Starling Oncology, Inc. (STLN)

10-Q 2022-11-09 For: 2022-09-30
View Original
Added on April 06, 2026

About this 10-Q

Starling Oncology, Inc filed this 10-Q on November 9, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).

Headline figures

Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$64.98M
up 24.3% from $52.28M a year earlier
Net loss
$2.67M
compared with a net loss of $2.98M a year earlier
Diluted EPS
-$0.17
compared with -$0.05 a year earlier